Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Idiopathic Normal Pressure Hydrocephalus
NCT02163330Phase 3Terminated
- Sponsor
- Rabin Medical Center
- Start
- Jun 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in Idiopathic Normal Pressure Hydrocephalus (NPH), sponsored by Rabin Medical Center. Started Jun 2014; status: terminated.
02
Drugs
acetazolamide
03
Conditions
Idiopathic Normal Pressure Hydrocephalus (NPH)
Beyond the preview
Go deeper on NCT02163330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163330.